Optimal Treatment Strategies for HIV with Antibody Response
نویسندگان
چکیده
منابع مشابه
Optimal HIV treatment by maximising immune response.
We present an optimal control model of drug treatment of the human immunodeficiency virus (HIV). Our model is based upon ordinary differential equations that describe the interaction between HIV and the specific immune response as measured by levels of natural killer cells. We establish stability results for the model. We approach the treatment problem by posing it as an optimal control problem...
متن کاملHIV Model Analysis Under Optimal Control Based Treatment Strategies
In this paper we describe a model of the immunologic response of the human immunodeficiency virus (HIV) in individuals. We illustrate how optimal control methodology can produce a drug dosing strategy and how this treatment strategy possesses features of structured treatment interruptions (STI). We then perform a sensitivity analysis of the model, illustrating use of both classical sensitivity ...
متن کاملOptimal Treatment Strategies for Tuberculosis with Exogenous Reinfection
Tuberculosis (TB) is a disease found in about one third of the world population. There is some controversy on the role of exogenous reinfection; with some epidemiologists supporting it while others consider it irrelevant. However, even at a minimal level, the presence of exogenous reinfection is capable of generating hysteresis and supporting multiple endemic states when the basic reproduction ...
متن کاملOptimal CD4 Count for Initiating HIV Treatment
BACKGROUND In HIV infection, dynamic marginal structural models have estimated the optimal CD4 for treatment initiation to minimize AIDS/death. The impact of CD4 observation frequency and grace periods (permitted delay to initiation) on the optimal regimen has not been investigated nor has the performance of dynamic marginal structural models in moderately sized data sets-two issues that are re...
متن کاملLung Cancer: Optimal Treatment Strategies
Objective: Search of best treatment plan for non-small lung cancer (LC) patients (LCP) was realized. Methods: In trial (1985-2008) the data of consecutive 535 LCP after complete resections (R0) (age = 57.3 ± 8.2 years; male-482, female-53; tumor diameter: D = 4.7 ± 2.2 cm; pneumonectomies-222, lobectomies-313, combined procedures with resection of pericardium, atrium, aorta, VCS, carina, diaphr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Applied Mathematics
سال: 2014
ISSN: 1110-757X,1687-0042
DOI: 10.1155/2014/685289